Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.37 - $1.69 $1.29 Million - $5.88 Million
-3,479,645 Reduced 94.72%
194,034 $151,000
Q2 2023

Aug 14, 2023

BUY
$0.39 - $1.69 $1.43 Million - $6.21 Million
3,673,679 New
3,673,679 $1.43 Million
Q4 2022

Feb 14, 2023

BUY
$2.09 - $4.32 $193,636 - $400,243
92,649 Added 345.61%
119,456 $275,000
Q3 2022

Nov 14, 2022

SELL
$2.24 - $4.18 $2.62 Million - $4.89 Million
-1,170,407 Reduced 97.76%
26,807 $73,000
Q2 2022

Aug 15, 2022

SELL
$2.85 - $7.77 $8.2 Million - $22.4 Million
-2,876,766 Reduced 70.61%
1,197,214 $3.41 Million
Q1 2022

May 16, 2022

BUY
$5.7 - $9.3 $13.5 Million - $22 Million
2,364,774 Added 138.36%
4,073,980 $30.9 Million
Q4 2021

Feb 14, 2022

BUY
$8.73 - $15.27 $3.08 Million - $5.39 Million
353,281 Added 26.05%
1,709,206 $14.9 Million
Q1 2021

May 17, 2021

SELL
$26.12 - $52.17 $5.1 Million - $10.2 Million
-195,093 Reduced 12.58%
1,355,925 $43.4 Million
Q4 2020

Feb 16, 2021

BUY
$14.05 - $29.0 $21.6 Million - $44.6 Million
1,539,128 Added 12944.73%
1,551,018 $38.2 Million
Q2 2020

Aug 14, 2020

SELL
$13.25 - $21.72 $977,836 - $1.6 Million
-73,799 Reduced 86.12%
11,890 $192,000
Q4 2019

Feb 14, 2020

BUY
$14.22 - $23.38 $462,050 - $759,686
32,493 Added 61.08%
85,689 $1.81 Million
Q3 2019

Nov 14, 2019

BUY
$22.93 - $41.06 $1.22 Million - $2.18 Million
53,196 New
53,196 $1.22 Million
Q1 2019

May 15, 2019

SELL
$28.11 - $50.77 $9.97 Million - $18 Million
-354,600 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$26.22 - $56.89 $14.7 Million - $31.8 Million
-559,100 Reduced 61.19%
354,600 $9.52 Million
Q3 2018

Nov 14, 2018

BUY
$24.31 - $52.74 $22.2 Million - $48.2 Million
913,700 New
913,700 $44.4 Million

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $3.12B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.